Viewing nowCombinationEmpamax M Tablet 5/1000 mg (Empagliflozin, Metformin)
Empagliflozin L-Proline 6.28mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.

MFDS item code 202107472 · Approved 2021.11.15 · Insurance code 643309950
Improvement of glycemic control in adults with type 2 diabetes
This medication is used in addition to dietary and exercise therapy to improve blood glucose control in adult patients with type 2 diabetes who are suited for combined therapy with empagliflozin and metformin. Special precautions are necessary for adult patients with type 2 diabetes who do not sufficiently control their blood glucose and have cardiovascular disease due to the increased risk of cardiovascular events, so it is important to also refer to professional information. This medication effectively manages blood sugar to assist in diabetes treatment.
The recommended dose of this medicine is 1 tablet twice daily. Determine the dose based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who cannot achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose 10 mg) plus the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medicine is administered concomitantly with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take twice the dose at one time; skip the missed dose in that case. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or CrCl of 45-59 ml/min who have no other condition that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, discontinue this medicine immediately (see Precautions for Use, 2. Patients in Whom This Medicine Is Contraindicated, item 2)). Older adults In patients aged 75 years or older, consider renal function and the risk of volume depletion.
This medication is used to help control blood sugar in diabetes treatment. This medication should not be used in patients with impaired renal function. It should not be administered in cases of moderate or severe renal impairment, acute kidney problems, dehydration, or severe infections. It is safer for women who are pregnant or breastfeeding not to use this medication, and women who may become pregnant should also avoid administration. Patients with severe heart failure or cardiovascular issues such as acute myocardial infarction or shock should not use this medication. This medication may cause hypoglycemia; therefore, dosage adjustment is necessary when used in conjunction with insulin or other hypoglycemic agents. During treatment, lactic acidosis, a rare but serious side effect, may occur, so if symptoms such as vomiting, muscle pain, difficulty breathing, or weakness appear, consult a doctor immediately. Additionally, this medication can increase the risk of urinary tract infections or genital infections, so prompt treatment is necessary when any symptoms of infection occur. During treatment, it is essential to monitor renal function, blood glucose, and vitamin B12 levels regularly. If undergoing surgery or radiographic contrast examinations, this medication should be discontinued for a specific period before and after the examination, and can be resumed after normal renal function has recovered. Elderly patients or those at risk of fluid loss should be cautious of dehydration or hypotension, and may need to temporarily discontinue medication if necessary. The risk of side effects increases when this medication is taken with alcohol, so it is advisable to avoid drinking. In case of overdose, there is a risk of lactic acidosis, and hospital treatment should be sought immediately, including possible dialysis. Keep this medication out of reach of children and store it in its original packaging.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to prevent air and moisture from entering, and it is recommended to keep it at room temperature between 1 degree and 30 degrees Celsius. Storing it this way will help maintain the medication's effectiveness.
Yellow, oval, bi-convex film-coated tablet with a brownish tint
60 tablets/box [10 tablets/PTP x 6], 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin L-Proline 6.28mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationEmpagliflozin L-Proline 15.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationEmpagliflozin L-Proline 15.7mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Chong Kun Dang
CombinationEmpagliflozin L-Proline 15.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Jonggeun Dang Co., Ltd.
CombinationEmpagliflozin L-Proline 6.28mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationEmpagliflozin L-Proline 6.28mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationEmpagliflozin L-Proline 12.55mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationEmpagliflozin L-Proline 31.38mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.